Ute Hamann
Impact in
- Genetics top 0.05%
- BRCA gene mutations in cancer
- Genetic Associations and Epidemiology
- Estrogen and related hormone effects
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Genetics 229
- BRCA gene mutations in cancer 187
- Genetic Associations and Epidemiology 84
- Estrogen and related hormone effects 10
-
- Breast Cancer Treatment Studies 20
- Co-authors
- Heinrich Gausepohlꝉ (1 shared paper)Sissel Rogne (1 shared paper)Joachim Herz (1 shared paper)Keith K. Stanley (1 shared paper)Ola Myklebost (1 shared paper)Muhammad Usman Rashid (27 shared papers)Rodney John Scott (14 shared papers)Sune Kvist (2 shared papers)
- Journals
- Breast Cancer Research and Treatment (21 papers)Breast Cancer Research (18 papers)Nature Genetics (14 papers)Cancer Epidemiology Biomarkers & Prevention (12 papers)JNCI Journal of the National Cancer Institute (10 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Ute Hamann
248 papers receiving 21.6k citations
Ute Hamann's Hit Papers
Peers
Comparison fields: 5 of 193
- Genetics 13.5k
- Cancer Research 2.5k
- Oncology 2k
- Reproductive Medicine 720
- Pathology and Forensic Medicine 742
Countries citing papers authored by Ute Hamann
This map shows the geographic impact of Ute Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hamann more than expected).
Fields of papers citing papers by Ute Hamann
This network shows the impact of papers produced by Ute Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hamann. The network helps show where Ute Hamann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ute Hamann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Hit paper breakdown → | 1998 | 2443 |
| 2 | Genome-wide association study identifies novel breast cancer susceptibility loci Hit paper breakdown → | 2007 | 1919 |
| 3 | Association analysis identifies 65 new breast cancer risk loci Hit paper breakdown → | 2017 | 1040 |
| 4 | Surface location and high affinity for calcium of a 500‐kd liver membrane protein closely related to the LDL‐receptor suggest a physiological role as lipoprotein receptor. Hit paper breakdown → | 1988 | 850 |
| 5 | RAD51B in Familial Breast Cancer Hit paper breakdown → | 2016 | 641 |
| 6 | 1998 | 579 | |
| 7 | Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Hit paper breakdown → | 2012 | 538 |
| 8 | 2005 | 517 | |
| 9 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer Hit paper breakdown → | 2015 | 489 |
| 10 | 2007 | 486 | |
| 11 | Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants Hit paper breakdown → | 2015 | 450 |
| 12 | 2009 | 408 | |
| 13 | Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer Hit paper breakdown → | 2015 | 406 |
| 14 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Hit paper breakdown → | 2017 | 368 |
| 15 | 2013 | 349 | |
| 16 | 2013 | 331 | |
| 17 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Hit paper breakdown → | 2020 | 321 |
| 18 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Hit paper breakdown → | 2017 | 306 |
| 19 | 2010 | 278 | |
| 20 | 2011 | 265 |
About Ute Hamann
Ute Hamann is a scholar working on Genetics, Cancer Research, Oncology, Pathology and Forensic Medicine and Pharmacology, having authored 255 papers that have together received 22.2k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (187 papers), Genetic Associations and Epidemiology (84 papers), Breast Cancer Treatment Studies (20 papers), Estrogen and related hormone effects (10 papers), Cancer Risks and Factors (10 papers), Breast Lesions and Carcinomas (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Genetics (13.5k citations), Cancer Research (2.5k citations), Oncology (2k citations), Reproductive Medicine (720 citations) and Pathology and Forensic Medicine (742 citations). Ute Hamann has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Heinrich Gausepohlꝉ, Sissel Rogne, Joachim Herz, Keith K. Stanley, Ola Myklebost, Muhammad Usman Rashid, Rodney John Scott, Sune Kvist, Asim Amin and Achim Wenzel. Their work appears in journals such as Breast Cancer Research and Treatment, Breast Cancer Research, Nature Genetics, Cancer Epidemiology Biomarkers & Prevention and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.